DNA microarray analysis as a tool to investigate the therapeutic mechanisms and drug development of Chinese medicinal herbs

BioMedicine (Netherlands)

Volumn 2, Issue 1, 2012, Pages 10-16

  Li, Chia Cheng ^a   Lo, Hsin Yi ^a   Hsiang, Chien Yun ^a   Ho, Tin Yun ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

DNA microarray; Gene expression profile; Traditional Chinese medicine

Indexed keywords

ANTHRAQUINONE; ARISTOLOCHIC ACID; COMPLEMENTARY DNA; CURCUMIN; GINKGO BILOBA EXTRACT; LIUWEIDIHUANG TANG; OLIGONUCLEOTIDE; PC SPES; PINELLIAE RHIZOMA EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; SAN HUANG XIE XIN TANG; UNCLASSIFIED DRUG; VANILLIN;

ALCOHOL DEHYDROGENASE GENE; ALDEHYDE DEHYDROGENASE GENE; ASTHMA; BIOCHEMICAL COMPOSITION; CHINESE MEDICINE; COUGHING; CYTOCHROME P450 GENE; DNA MICROARRAY; DNA PROBE; DOWN REGULATION; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; GENE; GENE EXPRESSION PROFILING; GENE TECHNOLOGY; GENETIC CODE; GLUTATHIONE S TRANSFERASE GENE; HUMAN; KIDNEY DISEASE; MENTAL DISEASE; MENTAL STRESS; MICROARRAY ANALYSIS; MICROCHIP ANALYSIS; MOLECULAR INTERACTION; MOLECULAR MODEL; NEOPLASM; NONHUMAN; NUCLEAR FACTOR KAPPA B GENE; PARKINSON DISEASE; PHYTOCHEMISTRY; PROSTATE CARCINOMA; REVIEW; STANDARDIZATION; SULFOTRANSFERASE GENE; UDP GLUCURONOSYLTRANSFERASE GENE; UPREGULATION;

EID: 84862784657     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2012.02.002     Document Type: Review

References (52)

1. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467-470.
2. Dufva M. Introduction to microarray technology. Methods Mol Biol 2009, 529:1-22.
3. Draghici S., Khatri P., Eklund A.C., Szallasi Z. Reliability and reproducibility issues in DNA microarray measurements. Trends Genet 2006, 22:101-109.
4. Marshall E. Getting the noise out of gene arrays. Science 2004, 306:630-631.
5. Kauffmann A., Huber W. Microarray data quality control improves the detection of differentially expressed genes. Genomics 2010, 95:138-142.
6. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001, 29:365-371.
7. Kubota T., Hisatake J., Hisatake Y., Said J.W., Chen S.S., Holden S., et al. PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo. Prostate 2000, 42:163-171.
8. Small E.J., Frohlich M.W., Bok R., Shinohara K., Grossfeld G., Rozenblat Z., et al. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 2000, 18:3595-3603.
9. Olaku O., White J.D. Herbal therapy use by cancer patients: a literature review on case reports. Eur J Cancer 2011, 47(4):508-514.
10. Bonham M., Arnold H., Montgomery B., Nelson P.S. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma. Cancer Res 2002, 62:3920-3924.
11. Hsieh M.T., Cheng S.J., Lin L.W., Wang W.H., Wu C.R. The ameliorating effects of acute and chronic administration of LiuWei Dihuang Wang on learning performance in rodents. Biol Pharm Bull 2003, 26:156-161.
12. Rho S., Kang M., Choi B., Sim D., Lee J., Lee E., et al. Effects of Yukmijihwang-tang derivatives (YMJd), a memory enhancing herbal extract, on the gene-expression profile in the rat hippocampus. Biol Pharm Bull 2005, 28:87-93.
13. Kim B.Y., Cho S.J., Kim H.W., Kim S.Y., Lim S.H., Kim K.O., et al. Genome wide expression analysis of the effect of Pinelliae Rhizoma extract on psychological stress. Phytother Res 2010, 24:384-392.
14. Govindarajan V.S. Turmeric: chemistry, technology and quality. Crit Rev Food Sci Nutr 1980, 12:199-301.
15. Huang M.T., Smart R.C., Wong C.Q., Conney A.H. Inhibitory effect of curcumin, chlorogenic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1988, 48:5941-5946.
16. Das L., Vinayak M. Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-κB signalling in lymphoma-bearing mice. Biosci Rep 2012, 32:161-170.
17. Chen H.W., Yu S.L., Chen J.J.W., Li H.N., Lin Y.C., Yao P.L., et al. Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol 2004, 65:99-110.
18. Lai M.N., Lai J.N., Chen P.C., Tseng W.L., Chen Y.Y., Hwang J.S., et al. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology 2009, 14:227-234.
19. Stengel B. Chronic kidney disease and cancer: a troubling connection. J Nephrol 2010, 23(3):253-262.
20. Pfohl-Leszkowicz A. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 2009, 60(4):465-483.
21. Chen Y.Y., Chiang S.Y., Wu H.C., Kao S.T., Hsiang C.Y., Ho T.Y., et al. Microarray analysis reveals the inhibition of nuclear factor-κB signaling by aristolochic acid in normal human kidney (HK-2) cells. Acta Pharmacol Sin 2010, 31:227-236.
22. Cheng W.Y., Wu S.L., Hsiang C.Y., Li C.C., Lai T.Y., Lo H.Y., et al. Relationship between San-Huang-Xie-Xin-Tang and its herbal components on the gene expression profiles in HepG2 cells. Am J Chin Med 2008, 36:783-797.
23. Aggarwal B.B., Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006, 71:1397-1421.
24. Chan E., Tan M., Xin J., Sudarsanam S., Johnson D.E. Interactions between traditional Chinese medicines and Western therapeutics. Curr Opin Drug Discov Devel 2010, 13:50-65.
25. Cheng W.Y., Lien J.C., Hsiang C.Y., Wu S.L., Li C.C., Lo H.Y., et al. Comprehensive evaluation of a novel nuclear factor-κB inhibitor, quinoclamine, by transcriptomic analysis. Br J Pharmacol 2009, 157:746-756.
26. Lirdprapamongkol K., Sakurai H., Kawasaki N., Choo M.K., Saitoh Y., Aozuka Y., et al. Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells. Eur J Pharm Sci 2005, 25:57-65.
27. Cheng W.Y., Hsiang C.Y., Bau D.T., Chen J.C., Shen W.S., Li C.C., et al. Microarray analysis of vanillin-regulated gene expression profile in human hepatocarcinoma cells. Pharmacol Res 2007, 56:474-482.
28. Liang J.A., Wu S.L., Lo H.Y., Hsiang C.Y., Ho T.Y. Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-κB signaling pathway in human hepatocellular carcinoma cells. Mol Pharmacol 2009, 75:151-157.
29. Chen T., Guo L., Zhang L., Shi L., Fang H., Sun Y., et al. Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinformatics 2006, 7. S20.
30. Watanabe C.M., Wolffram S., Ader P., Rimbach G., Packer L., Maguire J.J., et al. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proc Natl Acad Sci USA 2001, 98:6577-6580.
31. Zhang Z., Peng D., Zhu H., Wang X. Experimental evidence of Ginkgo biloba extract EGB as a neuroprotective agent in ischemia stroke rats. Brain Res Bull 2012, 87:193-198.
32. Su S.Y., Hsieh C.L., Wu S.L., Cheng W.Y., Li C.C., Lo H.Y., et al. Transcriptomic analysis of EGb 761-regulated neuroactive receptor pathway in vivo. J Ethnopharmacol 2009, 123:68-73.
33. Clarke P.A., te Poele R., Wooster R., Workman P. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem Pharmacol 2001, 62:1311-1336.
34. Sato H., Ishida S., Toda K., Matsuda R., Hayashi Y., Shigetaka M., et al. New approaches to mechanism analysis for drug discovery using DNA microarray data combined with KeyMolnet. Curr Drug Discov Technol 2005, 2:89-98.
35. Wang S., Cheng Q. Microarray analysis in drug discovery and clinical applications. Methods Mol Biol 2006, 316:49-65.
36. Gomase V.S., Tagore S., Kale K.V. Microarray: an approach for current drug targets. Curr Drug Metab 2008, 9:221-231.
37. Thomas R.S., Rank D.R., Penn S.G., Zastrow G.M., Hayes K.R., Pande K., et al. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol 2001, 60:1189-1194.
38. Ganter B., Tugendreich S., Pearson C.I., Ayanoglu E., Baumhueter S., Bostian K.A., et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol 2005, 119:219-244.
39. Liguori M.J., Anderson M.G., Bukofzer S., McKim J., Pregenzer J.F., Retief J., et al. Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin. Hepatology 2005, 41:177-186.
40. Afshari C.A., Nuwaysir E.F., Barrett J.C. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res 1999, 59:4759-4760.
41. Yengi L.G. Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches. Pharmacogenomics 2005, 6:185-192.
42. Whitfield M.L., George L.K., Grant G.D., Perou C.M. Common markers of proliferation. Nat Rev Cancer 2006, 6:99-106.
43. Scherf U., Ross D.T., Waltham M., Smith L.H., Lee J.K., Tanabe L., et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000, 24:236-244.
44. Gunther E.C., Stone D.J., Gerwien R.W., Bento P., Heyes M.P. Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci U S A 2003, 100:9608-9613.
45. Thomas R.S., Penn S.G., Holden K., Bradfield C.A., Rank D.R. Sequence variation and phylogenetic history of the mouse Ahr gene. Pharmacogenetics 2002, 12:151-163.
46. Lamb J., Crawford E.D., Peck D., Modell J.W., Blat I.C., Wrobel M.J., et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313:1929-1935.
47. Lam C.W., Lau K.C., Tong S.F. Microarrays for personalized genomic medicine. Adv Clin Chem 2010, 52:1-18.
48. Smalley J.L., Gant T.W., Zhang S.D. Application of connectivity mapping in predictive toxicology based on gene-expression similarity. Toxicology 2010, 268:143-146.
49. Cheng H.M., Li C.C., Chen C.Y., Lo H.Y., Cheng W.Y., Lee C.H., et al. Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluation. J Ethnopharmacol 2010, 132:429-437.
50. Smyth G.K., Speed T. Normalization of cDNA microarray data. Methods 2003, 31:265-273.
51. Montaner D., Tárraga J., Huerta-Cepas J., Burguet J., Vaquerizas J.M., Conde L., et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Res 2006, 34:W486-W491.
52. Zhang B., Schmoyer D., Kirov S., Snoddy J. GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics 2004, 5:16-23.